Jaber Ebne Hayyan Pharmaceutical Company (DJABER) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DJABER
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1404/09/30 | Report to 1403/09/30 | Report to 1401/12/29 | Report to 1400/09/30 |
|---|---|---|---|---|
| P/E TTM | 16.03 | 2.53 | 9.94 | 11.03 |
| P/S TTM | 1.43 | 1.66 | 5.26 | 5.15 |
| P/B | 1.93 | 1.50 | 4.91 | 4.88 |
| Gross margin TTM | 30.0% | 20.2% | 19.6% | 32.6% |
| Net margin TTM | 8.9% | 65.7% | 52.9% | 67.6% |
| ROA TTM | 5.4% | 31.5% | 22.3% | 16.4% |
| ROE TTM | 12.0% | 59.5% | 49.4% | 44.3% |
| Collection period TTM | 399 days | 421 days | 425 days | 484 days |
| Inventory period TTM | 77 days | 70 days | 131 days | 142 days |
| PEG TTM | 0.14 | - | - | 1.24 |
| PEGY TTM | 0.12 | - | - | 0.75 |